HIMS
Hims & Hers Health, Inc.Close $22.44EOD onlyThis page reflects HIMS options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Consensus-supported lens with chain history and key metrics in the rail.
Outlook
Neutral-to-bearish with a strong gravitational pull toward $20-$21 max pain clusters, but within a structurally wide and volatile range. Confidence: 4.5/10. The regime is defined by extreme volatility and a pinning force that conflicts with bearish flow and a spot price below key pain points.
Conflicts: Net premium flow is bearish (-$14.7M); Spot ($20.76) sits below the nearest max pain ($21.50 for 3/27); Extreme IV (102.3%) suggests unstable equilibrium.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $+40.7M
DEX: +32.7M shares
Gamma flip: ~$14 (Approx โ based on put OI concentration of 13,187)
NTM gamma: Positive GEX suggests dealers are net long gamma, hedging by buying dips and selling rallies, reinforcing range-bound action. A move ยฑ2% from here remains within the high-GEX zone, so dealer hedging should dampen volatility, not accelerate it.
IV Analysis
IV vs VIX: IV 102.3% is astronomically high โ the stock is priced for binary outcomes. Premium selling is compelling but carries extreme risk.
Term structure: Steeply upward sloping near-term (41% โ 80% in 3 weeks), then elevated and humped. Key kink: 5/08 expiry at 99.1% (near earnings 5/04).
Skew: The ~40 vol-point differential between 4/02 (41%) and 4/10 (74%) is a massive calendar spread opportunity for volatility sellers.
Flow Analysis
Net premium: -$14.7M bearish; P/C vol 0.54, P/C OI 0.60 โ indicates more call volume but put premium dominance.
Directional prints: $24C 4/10 vol 7,061 vs OI 2,321 โ could be bullish call buying or bearish call writing against shares. $20.50P 4/02 vol 1,862 vs OI 750 โ likely defensive put buying or put spread selling. The bearish premium flow favors the put-buying interpretation.
Unusual: $70P 6/18 vol 1,470 at IV 186% โ likely a cheap tail hedge or part of a complex structure, not a directional bet.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate-Weak | Buy shares at $20.76 | High IV and bearish flow suggest better entry via short puts; stock vulnerable to vol crush. |
| Short stock | Weak | Sell shares at $20.76 | Strong positive GEX and upward MP drift create headwinds; defined-risk puts are better. |
| Covered call | Moderate-Strong | Own stock, sell $23C 5/15 (45 DTE) for ~$1.00-1.20 | Capped upside at key OI wall; stock decline not protected. |
| Cash-secured put / put spread | Moderate-Strong | Sell $19/$17 put spread 4/17 (17 DTE) for ~$0.60-0.70 credit | Break below $19.49 2d EM low; defined risk is key. |
| Long calls | Weak | Buy $21C 4/17 for high debit | Extreme IV, pinning, and negative premium flow โ terrible setup for long premium. |
| Long puts / bear put spread | Moderate | Buy $20P / Sell $18P 4/10 for ~$0.80-0.90 debit | Pinning and positive GEX fight the move; only works on a clean break below $19.50. |
| Iron condor | Moderate | $19P/$17P x $23C/$25C 4/17 (within 1w EM bounds) | High IV (>80%) supports, but GEX positive and VIX context unknown; wide wings needed due to high vol. |
| Calendar/diagonal | Strong | Sell $21C 4/02 (41% IV) / Buy $21C 4/10 (74% IV) โ reverse calendar for credit. | Pin at $21; short leg decays rapidly; vol crush on near-term expiry benefits. |
| PMCC / LEAPS diagonal | Moderate | Buy $15C 1/2027, sell $23C 4/17 or 5/15 against it. | Long-dated IV still high (~89%); capital intensive but captures upward drift. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.